Walleye Capital’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Walleye Capital’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-112,103	Closed	-$1.49K	–	5574
2023 Q2	$1.49K	Sell	112,103 -20,071	-15%	-$620	﹤0.01%	4175
2023 Q1	$6.75K	Hold	132,174	–	–	﹤0.01%	3599
2022 Q4	$11.2K	Buy	132,174 +20,071	+18%	+$2.67K	﹤0.01%	2746
2022 Q3	$25K	Buy	112,103 +17,536	+19%	+$5.32K	﹤0.01%	2696
2022 Q2	$21K	Sell	94,567 -10,432	-10%	-$8.41K	﹤0.01%	1905
2022 Q1	$81K	Buy	104,999 +53,569	+104%	+$39.2K	﹤0.01%	1788
2021 Q4	$62K	Sell	51,430 -481	-0.9%	-$548	﹤0.01%	1758
2021 Q3	$52K	Buy	+51,911	New	+$54.5K	﹤0.01%	1392

Walleye Capital's GRNAW Position: Q3 2023 in Review

Walleye Capital sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 112,103 shares — an estimated $1.49K sold.

Walleye Capital first reported a position in GRNAW in Q3 2021 and held it in 8 quarters. The position peaked at $81K in Q1 2022. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

Walleye Capital reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
Walleye Capital sold 112,103 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $1.49K.
Walleye Capital first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q3 2021 and held it in 8 quarters.
Walleye Capital's GreenLight Biosciences Holdings, PBC Warrant position peaked at $81K in Q1 2022.
1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on Walleye Capital's 13F filing for Q3 2023, filed 14 Nov 2023.